News

5

May, 2021

Italy-Africa health research, collaborating for a better future

 

The Italian National Institute of Health has recently published a report on Italian health research in partnership with African Countries. The report, which Penta has contributed to, is based on a survey that has mapped out the collaborative health research activities that currently exist between Italy and Africa. Four of our studies namely, EPIICAL, ODYSSEY, PediCAP and SMILE and two studies which we are partners in, EMPIRICAL and NeoAMR, were included in the report. Through them, we are supporting research activities mainly at the benefit of institutions based in Africa […]

READ MORE

22

Apr, 2021

ZIKAction research in the face of COVID-19

Tags:

A recollection by Isadora Siqueira, Chief Investigator of the Paediatric Registry Study, on how the ZIKAction team in Brazil adapted to the challenges brought on by COVID-19 in order to carry on with their research and recruitment into the paediatric study.   What impact has the COVID-19 pandemic had on ZIKAction’s study activities and what solutions has your site identified to cope with it?   Brazil is one of the countries most affected by the COVID-19 pandemic and as of March 20th 2021, it had an incidence rate of 5,649 cases per 100,000 habitants, 4,726 cases per 100,000 women, [...]
READ MORE

15

Apr, 2021

Abbas Lugemwa speaks on ‘PentaTr@ining Uganda 2021’

Tags:

It was a lifetime privilege and honour to host the ‘PentaTr@ining Uganda 2021′ course. This training had originally been planned for 2020, but that schedule got disrupted due to the COVID-19 pandemic. Nevertheless, we still received all the maximum support to make the course happen this year. This was a declaration of trust by Penta Foundation in the work we do as Joint Clinical Research Centre – Mbarara, and a demonstration of commitment by Penta to build capacity for excellence in research and paediatric care.

READ MORE

2

Apr, 2021

Call for comments on the WHO Zika virus Research and Development Roadmap

Tags: ,

The WHO is calling on the public to share their comments on the newly drafted Zika virus Research and Development (R&D) Roadmap, a key component of the WHO’s R&D Blueprint which is a global strategy and preparedness plan that allows the activation of R&D activities in advance of and during pandemics. Comments can be submitted by completing this form. The Zika virus R&D roadmap aims to accelerate the development and implementation of effective medical countermeasures for the Zika virus so as to reduce morbidity, mortality and transmission of the virus. Zika is […]

READ MORE

25

Mar, 2021

Advancing the delivery of HIV Care

Tags:

On June 21-22, the International Workshop on Innovation in the delivery of HIV care will take place virtually. This is an important workshop highlighting the need for flexibility and innovation when it comes to caring for people living with HIV, to circumvent occurrences beyond our control that could negatively impact the type of care and treatment that healthcare workers provide. Participants will have the chance to share and learn how their peers provide care in terms of the innovative measures they introduced due to COVID-19, how they deliver HIV Care […]

READ MORE

22

Mar, 2021

ODYSSEY team at Radboud receives the RIHS Societal Award 2020

Tags:

As the world continues to raise its voice towards improving HIV treatment for children, the contributions made by the ODYSSEY trial have not gone unnoticed and as a result, has earned researchers the Radboud Institute for Health Sciences Societal Impact Award. “We are very proud to have received the Radboud Institute for Health Sciences Societal Impact Award 2020 for our work on a simplified dolutegravir dosing schedule for children of at least 20kg. This study, within the Odyssey trial, makes dolutegravir treatment possible for children living with HIV in Africa. […]

READ MORE

16

Mar, 2021

ZIKAHOST study shares findings on genetic predisposition to typical ZIKA effects at SEIP 2021

Tags: , ,

The ZIKAHOST study aims to describe the Zika virus (ZIKV) infection taking into account the host, in this case humans, instead of the pathogen, which would be the zika virus, and we search for biomarkers of the increased likelihood of developing the disease, diagnosis and prognosis through a genomic approach. What this means is that we look at DNA to see if we could understand if patients can be genetically predisposed to develop typical ZIKV effects. The study analysed 80 DNA samples from 40 mother and child pairs. The mothers […]

READ MORE

12

Mar, 2021

Sharing our understanding of the immune response of children living with HIV

Tags: , , ,

EPIICAL is proud to have presented four abstracts at the CROI conference this year, sharing updated information on viral decay and the immune response of children living with HIV who begin treatment early in life.   EFFECT OF HIV ON IMMUNE ACTIVATION AND EXHAUSTION IN CD4 AND CD8 T CELLS IN INFANTS Stefano Rinaldi, Vinh B. Dinh, Suresh Pallikkuth, Lesley D. Armas, Nadia Sitoe, Rajendra Pahwa, Nicola Cotugno, Paula Vaz, Paolo Palma, MariaGrazia Lain, Savita G. Pahwa DYNAMICS OF INTACT PROVIRAL SEQUENCES IN EARLY TREATED HIV-1 CLADE C–INFECTED INFANTS Catherine […]

READ MORE
NEWSLETTER

We would like to update you on our recent activities